Home > Research > Publications & Outputs > Anti-interleukin-13 and anti-interleukin-4 agen...

Electronic data

  • Edwards_et_al-2018-

    Rights statement: This is the Published version of the following article: Edwards M, Gallagher A, Nair P, Drew S, Vyas A, Sharma R, Marsden PA, Evans DJW. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012929. DOI: 10.1002/14651858.CD012929 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

    Final published version, 207 KB, PDF-document

    Embargo ends: 22/01/19

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma

Research output: Contribution to journalJournal article

Published
Close
<mark>Journal publication date</mark>22/01/2018
<mark>Journal</mark>Cochrane Database of Systematic Reviews
Issue number1
Number of pages13
<mark>State</mark>Published
<mark>Original language</mark>English

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the efficacy and safety of anti-interleukin-13 or anti-interleukin-4 agents, compared with placebo, anti-Immunoglobulin E agents, or anti-interleukin-5 agents, for the treatment of children, adolescents, or adults with asthma.

Bibliographic note

This is the Published version of the following article: Edwards M, Gallagher A, Nair P, Drew S, Vyas A, Sharma R, Marsden PA, Evans DJW. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012929. DOI: 10.1002/14651858.CD012929 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.